Holen Sie sich die Stockscreener-App
19.49
1.25%
0.24
Schlusskurs vom Vortag:
$19.25
Offen:
$19.36
24-Stunden-Volumen:
647.77K
Relative Volume:
0.57
Marktkapitalisierung:
$1.49B
Einnahmen:
$492.05M
Nettoeinkommen (Verlust:
$197.92M
KGV:
9.281
EPS:
2.1
Netto-Cashflow:
$176.12M
1W Leistung:
+6.85%
1M Leistung:
+11.05%
6M Leistung:
+5.47%
1J Leistung:
-14.37%
1-Tages-Spanne:
$19.36
$19.75
1-Wochen-Bereich:
$18.28
$19.83
52-Wochen-Spanne:
$14.87
$26.80
Inmode Ltd Stock (INMD) Company Profile
Vergleichen Sie INMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
19.49 | 1.49B | 492.05M | 197.92M | 176.12M | 2.10 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
InMode Ltd.'s (NASDAQ:INMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
(INMD) Investment Analysis and Advice - Stock Traders Daily
InMode to Report Third Quarter 2024 Financial Results and Hold C - GuruFocus.com
InMode to Present at Upcoming Investor Conferences - GuruFocus.com
InMode Ltd (INMD) Shares Gap Down to $17.9 on Nov 19 - GuruFocus.com
InMode Ltd. (NASDAQ:INMD) Receives Average Rating of "Hold" from Brokerages - MarketBeat
(INMD) Technical Pivots with Risk Controls - Stock Traders Daily
InMode to Present at Upcoming Investor Conferences – Company Announcement - Financial Times
We Think You Can Look Beyond InMode's (NASDAQ:INMD) Lackluster Earnings - Yahoo Finance
Finansavisen - Finansavisen
InMode: $25/Share Is Closer Than You Think (NASDAQ:INMD) - Seeking Alpha
Learn to Evaluate (INMD) using the Charts - Stock Traders Daily
P.A.W. Capital Corp Has $1.70 Million Stake in InMode Ltd. (NASDAQ:INMD) - MarketBeat
InMode Ltd. Just Recorded A 17% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St
InMode Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Earnings call: InMode revises 2024 guidance amid sales, operational challenges - Investing.com Australia
InMode Ltd. (NASDAQ:INMD) Q3 2024 Earnings Call Transcript - MSN
InMode: A Deep Dive After Q3 Earnings (NASDAQ:INMD) - Seeking Alpha
InMode Ltd. (NASDAQ:INMD) Holdings Trimmed by Meitav Investment House Ltd. - MarketBeat
InMode's (INMD) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
InMode Sees Revenue Growth Amidst Challenges in Q3 2024 - Yahoo Finance
InMode’s Q3 2024: Revenue Growth Amid Challenges - TipRanks
InMode: Q3 Earnings Snapshot - Houston Chronicle
InMode (INMD) Q3 2024 Earnings Call Transcript - Mitrade
InMode (INMD) Q3 2024 Earnings Call Transcript - The Motley Fool
InMode (NASDAQ:INMD) Releases FY24 Earnings Guidance - MarketBeat
InMode Beats Earnings, Cuts Guidance - The Motley Fool
InMode (INMD) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) – Company AnnouncementFT.com - Financial Times
What To Expect From InMode Ltd (INMD) Q3 2024 Earnings - Yahoo Finance
Boston Trust Walden Corp Has $23.87 Million Stock Position in InMode Ltd. (NASDAQ:INMD) - MarketBeat
InMode wins injunction against counterfeit device sellers By Investing.com - Investing.com Australia
InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories - The Malaysian Reserve
InMode wins injunction against counterfeit device sellers - Investing.com
Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline - Yahoo Finance
InMode (INMD) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
BTIG Initiates Coverage of InMode (INMD) with Buy Recommendation - MSN
InMode Ltd. (NASDAQ:INMD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Swedbank AB Sells 468,000 Shares of InMode Ltd. (NASDAQ:INMD) - MarketBeat
InMode Ltd (INMD) Shares Up 3.08% on Oct 18 - GuruFocus.com
InMode a new buy at BTIG on 'compelling' risk/reward prospects - Seeking Alpha
InMode (NASDAQ:INMD) Coverage Initiated at BTIG Research - MarketBeat
BTIG sets $25 target on InMode, cites growth potential - Investing.com India
BTIG sets $25 target on InMode, cites growth potential By Investing.com - Investing.com South Africa
InMode’s stock slides 13% after Israeli medtech company issues profit warning - MSN
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):